NCT04416321View on ClinicalTrials.gov

A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced.

NARecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Degenerative Disc DiseaseSpondylolisthesisRetrolisthesis
Interventions
DEVICE

Surgery with the Keos Lumbar Interbody Fusion Device

All subjects will received the Keos Lumbar Interbody Fusion Device if according to the investigators opinion they are clinically indicated to have surgery treatment for degenerative disc disease, spondylolisthesis and retrolisthesis

Trial Locations (1)

17601

RECRUITING

Neurosurgical Associates of Lancaster, Lancaster

Sponsors

Lead Sponsor

Invibio Ltd
All Listed Sponsors
collaborator

Keos LLC

UNKNOWN

collaborator

Medical Metrics Diagnostics, Inc

INDUSTRY

collaborator

Technomics Research

INDUSTRY

collaborator

Viedoc Technologies

UNKNOWN

lead

Invibio Ltd

INDUSTRY

NCT04416321 - A Clinical Study to Evaluate Safety and Performance of PEEK-OPTIMA™ HA Enhanced. | Biotech Hunter | Biotech Hunter